DesiCorp, Inc.
PrivateLast Round
Seed Round
Apr 1, 2026
Total Funding Raised
$8.7M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
DesiCorp, Inc. is a biotechnology company that develops technology to freeze-dry red blood cells and other therapeutics to extend their shelf-life without refrigeration.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Advanced Materials, Defense Tech, Pharma Supply Chain
Business Model
B2G
Customer Profile
Government Contracts, Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
DesiCorp, Inc. Comparables
Compare DesiCorp, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| KaloCyte, Inc. | 85% | |
| Cellphire Therapeutics | 81% | |
| Safi Biotherapeutics | 75% |
DesiCorp, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Apr 1, 2026 | ||||
| Seed | Nov 1, 2025 | ||||
| Grant | Jul 31, 2023 | ||||
| VC Round | Oct 1, 2022 |
DesiCorp, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Keyhorse Capital | VC Round, Seed |
| NIH RADx | Grant |
| Kentucky Cabinet for Economic Development | Grant |
| Medical Technology Enterprise Consortium | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 1, 2026
$840K raised in Seed Round.
- Nov 9, 2025
Monthly visitors increased 259% MoM.
DesiCorp, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access